ABVC - ABVC BioPharma reports Q3 results
ABVC BioPharma (NASDAQ:ABVC): Q3 GAAP EPS of -$0.07. Revenue of $98,999 vs. $115,553 in 3Q20. Press Release
For further details see:
ABVC BioPharma reports Q3 resultsThis is an AMP page which is for mobile devices.
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
For further details see:
ABVC BioPharma reports Q3 resultsNews, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.